Evidence map›Paper›PMID 28895901›Full record

ArticleCells2017

Delayed Activation Kinetics of Th2- and Th17 Cells Compared to Th1 Cells.

Andrea Duechting, Anna Przybyla, Stefanie Kuerten, Paul V Lehmann

Abstract read
In one paragraph

Article in Cells, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Role and plasticity of Th1 and Th17 responses in immunity toHuman vaccines & immunotherapeutics · 2019
    Trial
  3. Article
  4. Sez6L2 autoimmunity induces cerebellar ataxia in mice.Journal of neuroinflammation · 2025
    Article
  5. The Impact ofAntioxidants (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrea DuechtingR & D Department CTL, Shaker Hts, OH 44122, USA. andrea.duchting@immunospot.com.
Anna PrzybylaR & D Department CTL, Shaker Hts, OH 44122, USA. anna.przybyla@immunospot.com.
Stefanie KuertenDepartment Anatomy, University Erlangen, 91054 Erlangen, Germany. stefanie.kuerten@fau.de.ORCID 0000-0001-6119-605X
Paul V LehmannR & D Department CTL, Shaker Hts, OH 44122, USA. paul.lehmann@immunospot.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During immune responses, different classes of T cells arise: Th1, Th2, and Th17. Mobilizing the right class plays a critical role in successful host defense and therefore defining the ratios of Th1/Th2/Th17 cells within the antigen-specific T cell repertoire is critical for immune monitoring purposes. Antigen-specific Th1, Th2, and Th17 cells can be detected by challenging peripheral blood mononuclear cells (PBMC) with antigen, and establishing the numbers of T cells producing the respective lead cytokine, IFN-γ and IL-2 for Th1 cells, IL-4 and IL-5 for Th2, and IL-17 for Th-17 cells, respectively. Traditionally, these cytokines are measured within 6 h in flow cytometry. We show here that 6 h of stimulation is sufficient to detect peptide-induced production of IFN-γ, but 24 h are required to reveal the full frequency of protein antigen-specific Th1 cells. Also the detection of IL-2 producing Th1 cells requires 24 h stimulation cultures. Measurements of IL-4 producing Th2 cells requires 48-h cultures and 96 h are required for frequency measurements of IL-5 and IL-17 secreting T cells. Therefore, accounting for the differential secretion kinetics of these cytokines is critical for the accurate determination of the frequencies and ratios of antigen-specific Th1, Th2, and Th17 cells.

Indexed as

CD4 cellscytokine kineticsELISPOTimmune monitoringmultiplexingT cells

Identifiers

PMID28895901
PMCPMC5617975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.